Using music to improve cognitive function in people with mild Alzheimer's disease

Gamma-Music Based Intervention for Mild Alzheimer's Disease

['FUNDING_R01'] · NORTHEASTERN UNIVERSITY · NIH-10908522

This study is exploring how listening to music can help boost memory and motivation for people with mild Alzheimer's disease, making it a fun way to support brain health and improve daily life.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorNORTHEASTERN UNIVERSITY (nih funded)
Locations1 site (BOSTON, UNITED STATES)
Trial IDNIH-10908522 on ClinicalTrials.gov

What this research studies

This research investigates how music-based interventions can enhance cognitive function and motivation in individuals with mild Alzheimer's disease. By utilizing gamma-frequency auditory stimulation, the study aims to promote healthy neurocognitive aging and improve memory performance. Participants will engage in music listening activities designed to stimulate brain networks involved in sensory processing and social bonding. The approach is based on previous findings that suggest such interventions can reduce amyloid plaques and improve cognitive abilities in older adults.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with mild Alzheimer's disease who are experiencing cognitive deficits.

Not a fit: Patients with advanced Alzheimer's disease or those with other severe cognitive impairments may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies that enhance cognitive function and quality of life for patients with mild Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results using similar gamma-frequency stimulation techniques in animal models and older adults, indicating potential for success in human applications.

Where this research is happening

BOSTON, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.